Folic acid deficiency enhances oral contraceptive-induced platelet hyperactivity.
In previous studies conducted in female rats and in women, oral contraceptives (OC) were found to induce a platelet hyperactivity that was related to an oxidative stress. Because cases of megaloblastic anemia have been reported to occur in women taking OC, these treatments are suspected of depleting folate stores. In the study presented herein, which was conducted in rats, we sought to determine the influence of dietary folic acid deficiency (FD) on the thrombogenicity of OC. Animals were fed for 6 weeks with either a folic acid-deficient diet (250 micrograms/kg folic acid) or a control diet (750 micrograms/kg). One-half of the animals in each group were treated with OC (ethinyl estradiol plus lynestrenol). FD and OC individually potentiated platelet aggregation in response to thrombin and ADP and the release and metabolism of arachidonic acid, in particular, the biosynthesis of thromboxane. These platelet activities were further enhanced in animals given both the folic acid-deficient diet and the OC treatment. In addition, FD enhanced the pro-oxidant state in OC-treated rats characterized by (1) a fall in platelet and plasma n-3 fatty acids, (2) an increase in plasma lipid peroxidation products such as conjugated dienes, lipid peroxides, and thiobarbituric reactive substances, (3) a rise in ex vivo erythrocyte susceptibility to free radicals. Moreover, we found that OC treatment led to a reduction of plasma and erythrocyte folate concentrations associated with a moderate hyperhomocysteinemia. Under our experimental conditions, we did not find significant synergistic effects between OC and FD. We propose that, although the untoward effects associated with the OC treatment may not primarily be dependent on FD, the folic acid deficiency magnified OC-induced oxidative stress, which resulted in platelet hyperactivity by elevating the pro-oxidant homocysteine plasma concentration. Despite the limitations of this animal model, the data of the present study suggest that in addition to cigarette smoking, inadequate folic acid intake might predispose those taking OC to vascular thrombosis.
Durand
P
P
INSERM CJF 93-10, Laboratoire de Biochimie des Lipoprotéines, Faculté de Médecine, Université de Bourgogne, Dijon, France.
Prost
M
M
Blache
D
D
D000818:Animals; D016718:Arachidonic Acid / Q000378:metabolism; D001792:Blood Platelets / Q000187:drug effects* / Q000378:metabolism; D003276:Contraceptives, Oral / Q000633:toxicity*; D005227:Fatty Acids / Q000097:blood; D005260:Female; D005494:Folic Acid Deficiency / Q000097:blood*; D005609:Free Radicals; D006710:Homocysteine / Q000097:blood; D015227:Lipid Peroxidation; D018384:Oxidative Stress; D051381:Rats; D017207:Rats, Sprague-Dawley
D003276:Contraceptives, Oral; D005227:Fatty Acids; D005609:Free Radicals; D006710:Homocysteine; D016718:Arachidonic Acid